Accéder au contenu
Merck

Heterocyclic bibenzimidazole derivatives as topoisomerase I inhibitors.

Bioorganic & medicinal chemistry letters (2000-04-27)
S Jin, J S Kim, S P Sim, A Liu, D S Pilch, L F Liu, E J LaVoie
RÉSUMÉ

A series of 2'-heterocyclic derivatives of 5-phenyl-2,5'-1H-bibenzimidazoles were evaluated for topoisomerase I poisoning activity and cytotoxicity. Topo I poisoning activity was associated with 2'-derivatives that possessed a hydrogen atom capable of hydrogen bond formation, suggesting that the interatomic distances between such hydrogen atoms and the heteroatoms on the adjacent benzimidazole influence activity.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Indole-5-carboxaldehyde, 98%